Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V GLASS

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Psychiatry|August 15, 2024
The 24-Year Course of Symptomatic Disorders in Patients With Borderline Personality Disorder and Personality-Disordered Comparison Subjects: Description and Prediction of Recovery From BPDMary C Zanarini, Frances R Frankenburg, Isabel V Glass, et al.
The Journal of Physical Chemistry. A|July 13, 2006
Surfactant control of gas uptake: effect of butanol films on HCl and HBr entry into supercooled sulfuric acidJennifer R Lawrence, Samuel V Glass, Seong-Chan Park, et al.
Current Medical Research and Opinion|January 6, 2006
Development of an algorithm for using PINP to monitor treatment of patients with teriparatideRichard Eastell, John H Krege, Peiqi Chen, et al.
Calcified Tissue International|October 19, 2010
Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosisJulie Satterwhite, Michael Heathman, Paul D Miller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 17, 2008
Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosisR Lindsay, P Miller, G Pohl, et al.
Borderline Personality Disorder and Emotion Dysregulation|October 8, 2023
Course and predictors of social security disability insurance in patients with borderline personality disorder over 24 years of prospective follow-upUeli Kramer, Christina M Temes, Frances R Frankenburg, et al.
Borderline Personality Disorder and Emotion Dysregulation|March 3, 2024
Experiential avoidance in participants with borderline personality disorder and other personality disordersTess C Gecha, Isabel V Glass, Frances R Frankenburg, et al.
The Journal of Clinical Psychiatry|October 31, 2024
Sustained Symptomatic Remission and Recovery and Their Loss Among Patients With Borderline Personality Disorder and Patients With Other Types of Personality Disorders: A 24-Year Prospective Follow-Up StudyMary C Zanarini, Frances R Frankenburg, Katherine E Hein, et al.
Arthritis and Rheumatism|December 14, 2004
Association of severe vertebral fractures with reduced quality of life: reduction in the incidence of severe vertebral fractures by teriparatideG G Crans, S L Silverman, H K Genant, et al.
Journal of Affective Disorders|November 29, 2024
Emptiness in patients with borderline personality disorder: Severity and predictors of outcome over 24 years of prospective follow-upKatherine E Hein, Isabel V Glass, Frances R Frankenburg, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Psychiatry|August 15, 2024
The 24-Year Course of Symptomatic Disorders in Patients With Borderline Personality Disorder and Personality-Disordered Comparison Subjects: Description and Prediction of Recovery From BPDMary C Zanarini, Frances R Frankenburg, Isabel V Glass, et al.
The Journal of Physical Chemistry. A|July 13, 2006
Surfactant control of gas uptake: effect of butanol films on HCl and HBr entry into supercooled sulfuric acidJennifer R Lawrence, Samuel V Glass, Seong-Chan Park, et al.
Current Medical Research and Opinion|January 6, 2006
Development of an algorithm for using PINP to monitor treatment of patients with teriparatideRichard Eastell, John H Krege, Peiqi Chen, et al.
Calcified Tissue International|October 19, 2010
Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosisJulie Satterwhite, Michael Heathman, Paul D Miller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 17, 2008
Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosisR Lindsay, P Miller, G Pohl, et al.
Borderline Personality Disorder and Emotion Dysregulation|October 8, 2023
Course and predictors of social security disability insurance in patients with borderline personality disorder over 24 years of prospective follow-upUeli Kramer, Christina M Temes, Frances R Frankenburg, et al.
Borderline Personality Disorder and Emotion Dysregulation|March 3, 2024
Experiential avoidance in participants with borderline personality disorder and other personality disordersTess C Gecha, Isabel V Glass, Frances R Frankenburg, et al.
The Journal of Clinical Psychiatry|October 31, 2024
Sustained Symptomatic Remission and Recovery and Their Loss Among Patients With Borderline Personality Disorder and Patients With Other Types of Personality Disorders: A 24-Year Prospective Follow-Up StudyMary C Zanarini, Frances R Frankenburg, Katherine E Hein, et al.
Arthritis and Rheumatism|December 14, 2004
Association of severe vertebral fractures with reduced quality of life: reduction in the incidence of severe vertebral fractures by teriparatideG G Crans, S L Silverman, H K Genant, et al.
Journal of Affective Disorders|November 29, 2024
Emptiness in patients with borderline personality disorder: Severity and predictors of outcome over 24 years of prospective follow-upKatherine E Hein, Isabel V Glass, Frances R Frankenburg, et al.
Pageof 5